Features | Welcome to
OsseoTECH, a site devoted to chronicling osseointegration developments Please send suggestions for features.
|
Sponsors |
|
Links |
CDE-Directory - A Comprehensive Guide to Continuing Dental Education
OsseoNews - The World of Implant Dentistry Online
PalmDMD - PDA's in clinical dentistry
Medgadget - Emerging Medical Technologies
PalmDDS - PDA's in clinical dentistry
CurrentJournals - Keeping you updated Automatically - Keywords, Journals, Authors delivered weekly in an easy to read PDF format
|
|
NobelDirect - Analysts` Report on Bone Loss Controversy |
Posted by:Editor
on Thursday October 5th, 2006
|
Merrill Lynch and UBS have released stock research reports regarding Nobel Biocare`s NobelDirect implant design. Several recent studies suggest more than 3mm of bone loss in 14-55% of patients. An expert panel advising the Swedish Medical Products Agency on the safety of the NobelDirect implant has responded to a recent Nobel Biocare rebuttal letter in a critical manner. The Merrill Lynch analyst suggests a NobelDirect withdrawal may be ahead.
More
UBS Report <<< Back E-Mail This Topic: Implant Design
|
|
 |
! There are no comments posted for this item yet.
| |